Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute–Designated Cancer Center
Journal of the National Comprehensive Cancer Network · 2025-10 · 23 (10)
DOI: 10.6004/jnccn.2025.7059 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-10. Verfasst von Steven Tohmasi und 11 weiteren Autor:innen. Beteiligte Einrichtung: 1Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO. Hauptthemen laut MEDLINE: Smoking Cessation, Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDA NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
Background
Although evidence-based tobacco cessation treatments are recommended for all patients with cancer who smoke, they are often underutilized in routine oncology care due to time and resource constraints and limited understanding of the impact of smoking cessation on long-term outcomes in patients with advanced-stage cancer. This study aimed to evaluate the association between smoking cessation and overall survival (OS) in cancer survivors who smoke, across all disease stages.
Methods
We conducted an observational cohort study of 13,282 patients diagnosed with cancer who were evaluated in our outpatient oncology clinics between June and December 2018. Patients who smoked were prospectively followed to evaluate smoking cessation rates over the following 6 months. We assessed the impact of index-visit smoking status and smoking cessation within 6 months on 2-year OS using multivariable Cox proportional hazards models and the Kaplan-Meier method.
Results
Compared with patients who never smoked (n=6,568; 49.5%), those who reported currently smoking (n=1,725; 13.0%) (adjusted hazard ratio for death [aHR], 1.35; CI, 1.20–1.53) or having previously smoked (n=4,989; 37.6%) (aHR, 1.13; CI, 1.03–1.25) at their index visit had increased risk of all-cause mortality. Only 22.1% (n=381) of patients who reported currently smoking at their index visit quit smoking within 6 months. In multivariable analyses, patients who continued to smoke had a higher risk of all-cause mortality (aHR, 1.97; CI, 1.53–2.55) compared with those who had quit smoking. Subgroup analyses by cancer stage revealed an association between continued smoking and all-cause mortality in patients with advanced-stage (III or IV) cancer (aHR, 2.11; 95% CI, 1.60–2.79).
Conclusions
Postdiagnosis smoking cessation is associated with improved OS in cancer survivors, including those with advanced-stage cancer. Smoking cessation support should be provided to all cancer survivors who smoke, irrespective of cancer type or stage. Promoting smoking cessation in oncology care settings via systematic implementation efforts may aid in reducing smoking and mortality rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO.
- 2Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO.
- 3Center for Tobacco Research and Intervention, University of Wisconsin, Madison, WI.
- 4Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI.
- 5Department of Psychiatry, Washington University School of Medicine, St. Louis, MO.
- 6Department of Otolaryngology, Mercy David C. Pratt Cancer Center, St. Louis, MO.
Förderung
- NCI NIH HHS
- NIDA NIH HHS
- Wellcome Trust
Zitieren
APA
Tohmasi, S., Baker, T. B., Heiden, B. T., Chen, J., Smock, N., Craig, E. J., Griffith, N. B., Reddy, J., Colditz, G. A., Govindan, R., Bierut, L. J., & Chen, L. S. (2025). Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute–Designated Cancer Center. Journal of the National Comprehensive Cancer Network, 23(10). https://doi.org/10.6004/jnccn.2025.7059
Vancouver
Tohmasi S, Baker TB, Heiden BT, Chen J, Smock N, Craig EJ, et al. Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute–Designated Cancer Center. Journal of the National Comprehensive Cancer Network. 2025;23(10). doi:10.6004/jnccn.2025.7059
BibTeX
@article{Tohmasi2025,
author = {Tohmasi, Steven and Baker, Timothy B and Heiden, Brendan T and Chen, Jingling and Smock, Nina and Craig, Ethan J and Griffith, Nicholas B and Reddy, James and Colditz, Graham A and Govindan, Ramaswamy and Bierut, Laura J and Chen, Li-Shiun},
title = {Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute–Designated Cancer Center},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
volume = {23},
number = {10},
doi = {10.6004/jnccn.2025.7059}
}
EUVIMED